Skip to site menu Skip to page content

Daily Newsletter

08 August 2023

Daily Newsletter

08 August 2023

Westmead Hospital’s dedicated cystic fibrosis ward opens in Sydney

The A$65m facility is expected to provide specialised care and treatment for adults living with cystic fibrosis.

August 08 2023

Australia's New South Wales (NSW) Government has announced the opening of the purpose-built Cystic Fibrosis Specialist Service ward at Westmead Hospital in western Sydney for adults with cystic fibrosis.

The A$65m ($42.73m) Australia's first dedicated ward will provide specialised care and treatment for adults living with this genetic disorder that affects the lungs and digestive systems.

It is funded by the Commonwealth Government and includes a 16-bed inpatient unit with isolation rooms and an outpatient unit with ten consultation rooms, day-stay patient rooms, and research areas for diagnostic services and clinical trials.

Federal Minister for Health Mark Butler said: “There is no cure for cystic fibrosis but treatment has come a long way, and with an improvement in treatment comes an increase in the life expectancy of people living with the condition.

“On average, a person with cystic fibrosis needs to be admitted to a hospital once a year which requires a high level of multidisciplinary care from doctors, nurses, physiotherapists and dietitians.

“This service will make a big difference to patients and their families.”

The facility in the Westmead Health Precinct claims to contribute to the area's healthcare, education, research, and innovation.

Meanwhile, the Australian Government has fulfilled its commitment to Western Sydney residents by opening the Medicare Urgent Care Clinic at the Wentworthville Medical and Dental Centre.

The pilot Urgent Care Service, previously operating at the centre, has transitioned into a UCC, offering extended hours and seven-day-a-week access without appointments.

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close